SLC22A3 and prostate carcinoma: However, in prostate cancer tissues, the C/T heterozygous genotype exhibits a higher SLC22A3 transcription level than homozygous genotypes (C/C, T/T), suggesting a complex, non-canonical regulatory mechanism at play in cancerous tissues.